A new definition of obesity could nearly double the prevalence of U.S. adults with the condition, a new study published Monday finds.

Brian Lian founded publicly traded Viking Therapeutics to focus on metabolic diseases. With obesity drugs in development and the GLP-1 space booming, it’s now a prime M&A target for giants jostling for their share of a potential $100 billion market.

Junk food adverts will be banned on television and online from Monday as plans to tackle childhood obesity come into force across the UK. The ban will stop food and drinks high in fat, salt and sugar (HFSS) being advertised on TV before 21:00 and at any time online.

MetaVia has shared an update on its attempt to crash the obesity party, reporting average weight loss of 9.1% in people who received its dual agonist of GLP-1 and glucagon in a phase 1 trial.

At least 12% of adults in the U.S. have been prescribed a glucagon‐like peptide‐1 drug for one or multiple indications, but 54% of users report affordability challenges.

UK experts are warning that access to new weight-loss drugs could depend more on wealth than medical need. Strict NHS criteria mean only a limited number of patients will receive Mounjaro, while many others must pay privately.

Addressing Louisiana's obesity epidemic." This series will shine a spotlight on one of Louisiana’s biggest wellness issues and the efforts required

Oprah Opens Up About Obesity, GLP-1s and Her Healthy New Life: 'I've Never Felt Stronger'. In PEOPLE's new cover story, the icon, who's turning 72 and has co-written a new book on obesity, shares her

Novo Nordisk's Wegovy pill is the first and only oral GLP-1 for weight loss in adults. Scientists respond to RFK Jr.’s aluminum alarm Steelers poke fun at Ravens after big win, topping NFL trolls Mick